DE602008003411D1 - Verwendung von d-ribose zur behandlung von vorhofflimmern - Google Patents

Verwendung von d-ribose zur behandlung von vorhofflimmern

Info

Publication number
DE602008003411D1
DE602008003411D1 DE602008003411T DE602008003411T DE602008003411D1 DE 602008003411 D1 DE602008003411 D1 DE 602008003411D1 DE 602008003411 T DE602008003411 T DE 602008003411T DE 602008003411 T DE602008003411 T DE 602008003411T DE 602008003411 D1 DE602008003411 D1 DE 602008003411D1
Authority
DE
Germany
Prior art keywords
ribose
liabilities
previous
treatment
atrial fibrillation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008003411T
Other languages
English (en)
Inventor
James D Herrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioenergy Inc
Original Assignee
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenergy Inc filed Critical Bioenergy Inc
Publication of DE602008003411D1 publication Critical patent/DE602008003411D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE602008003411T 2007-01-23 2008-01-23 Verwendung von d-ribose zur behandlung von vorhofflimmern Active DE602008003411D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88194007P 2007-01-23 2007-01-23
PCT/US2008/000845 WO2008091618A1 (en) 2007-01-23 2008-01-23 Use of d-ribose to treat cardiac arrhythmias

Publications (1)

Publication Number Publication Date
DE602008003411D1 true DE602008003411D1 (de) 2010-12-23

Family

ID=39264528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008003411T Active DE602008003411D1 (de) 2007-01-23 2008-01-23 Verwendung von d-ribose zur behandlung von vorhofflimmern

Country Status (10)

Country Link
US (1) US8101581B2 (de)
EP (1) EP2120968B1 (de)
JP (1) JP5396387B2 (de)
CN (1) CN101588807B (de)
AT (1) ATE487485T1 (de)
BR (1) BRPI0806231A2 (de)
CA (1) CA2674717C (de)
DE (1) DE602008003411D1 (de)
ES (1) ES2352154T3 (de)
WO (1) WO2008091618A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
JP5396387B2 (ja) 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
CA2757442A1 (en) * 2008-04-02 2009-10-08 Bioenergy, Inc. Use of ribose in first response to acute myocardial infarction
EP3411041A1 (de) 2016-02-01 2018-12-12 RiboCor, Inc. Verwendung von ribose zur behandlung von personen mit herzinsuffizienz

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4719201A (en) * 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4824660A (en) * 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
RU2127548C1 (ru) * 1996-06-26 1999-03-20 Алабовский Владимир Владимирович Способ коронарографии в эксперименте
DE19650754A1 (de) * 1996-12-06 1998-06-10 Wolfgang Dr Pliml Ribose und Schlaganfall
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6218366B1 (en) * 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6429198B1 (en) * 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6534480B2 (en) * 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6339716B1 (en) * 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6511964B2 (en) * 1999-09-24 2003-01-28 Bioenergy, Inc. Method for treating acute mountain sickness
US6703370B1 (en) * 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
EP1244353B1 (de) * 1999-12-21 2004-11-17 Viacell, LLC Zusammensetzungen zur lagerung von blutplättchen
EP1282424A1 (de) * 2000-01-07 2003-02-12 Bioenergy Inc. Zusammenstellungen zur Erhöhung der Immunantwort
WO2001052831A1 (en) * 2000-01-20 2001-07-26 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US20030212006A1 (en) * 2002-05-13 2003-11-13 Seifert John G. Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
US8486859B2 (en) * 2002-05-15 2013-07-16 Bioenergy, Inc. Use of ribose to enhance plant growth
US7687468B2 (en) * 2003-05-14 2010-03-30 Viacell, LLC. Rejuvenation of stored blood
US8759315B2 (en) * 2003-05-14 2014-06-24 Viacell, Llc Methods for rejuvenating
US20040229205A1 (en) * 2003-05-16 2004-11-18 Ericson Daniel G. Compositions for the storage of platelets
US20070105787A1 (en) * 2004-01-14 2007-05-10 St Cyr John A Use of ribose in recovery from anaesthesia
ES2393786T3 (es) * 2004-04-29 2012-12-28 Ribocor, Inc. Método para mejorar la eficacia ventilatoria
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
US8835396B2 (en) * 2006-12-15 2014-09-16 Bioenergy, Inc. Method and compositions for improving pulmonary hypertension
JP5396387B2 (ja) 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
US20090197819A1 (en) * 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20080312169A1 (en) * 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
US20090232750A1 (en) * 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
CA2757442A1 (en) * 2008-04-02 2009-10-08 Bioenergy, Inc. Use of ribose in first response to acute myocardial infarction
US20090286750A1 (en) * 2008-05-16 2009-11-19 Kasubick Robert V Use of ribose in lessening the clinical symptoms of aberrant firing of neurons

Also Published As

Publication number Publication date
EP2120968A1 (de) 2009-11-25
BRPI0806231A2 (pt) 2011-09-06
ATE487485T1 (de) 2010-11-15
CN101588807B (zh) 2012-07-04
CA2674717A1 (en) 2008-07-31
ES2352154T3 (es) 2011-02-16
US8101581B2 (en) 2012-01-24
CA2674717C (en) 2015-10-13
JP5396387B2 (ja) 2014-01-22
WO2008091618A1 (en) 2008-07-31
US20080176809A1 (en) 2008-07-24
WO2008091618A8 (en) 2010-04-01
EP2120968B1 (de) 2010-11-10
JP2010526884A (ja) 2010-08-05
CN101588807A (zh) 2009-11-25

Similar Documents

Publication Publication Date Title
EA201100564A1 (ru) Антипролиферативные соединения
MY147247A (en) Organic compounds and their uses
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
EA201100794A1 (ru) Замещенные пиримидины, предназначенные для лечения заболеваний, таких как рак
EA201270803A1 (ru) Тиоацетатные соединения, композиции на их основе и способы их применения
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
MY170728A (en) Treatment for diabetes in patients inappropriate for metformin therapy
EA201000105A1 (ru) Химические соединения
TN2011000482A1 (en) Organic compounds and their uses
WO2009044173A3 (en) Methods of treating cancer using notch pathway inhibitors
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
BRPI0909447A2 (pt) Composição, métodos para tratar um indivíduo humano ou animal em necessidade de tal tratamento e para matar ou inibir o crescimento de microrganismos suscetíveis, e, uso de uma composição
EA200802329A1 (ru) Производные триазола ii
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
EA201100255A1 (ru) 5-алкинилпиримидины
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
CY1116216T1 (el) Μεθοδος θεραπειας ασθενειας αποθηκευσης γλυκογονου
EA201100872A1 (ru) Производные хиназолинамида
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита
NO20076405L (no) Anvendelse av 24-nor-UDCA